A Phase I Study of GSK2816126, an Enhancer of Zeste Homolog 2(EZH2) Inhibitor, in Patients (pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Other Non-Hodgkin Lymphomas (NHL), Transformed Follicular Lymphoma (tFL), Solid Tumors and Multiple Myeloma (MM)

MLA

Yap, Timothy Anthony, et al. A Phase I Study of GSK2816126, an Enhancer of Zeste Homolog 2(EZH2) Inhibitor, in Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Other Non-Hodgkin Lymphomas (NHL), Transformed Follicular Lymphoma (TFL), Solid Tumors and Multiple Myeloma (MM). Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......4485..5181800bebed5cf8952e55b55696f0b9&authtype=sso&custid=ns315887.

APA

Yap, T. A., Winter, J. N., Leonard, J. P., Ribrag, V., Constantinidou, A., Giulino-Roth, L., Michot, J.-M., Khan, T. A., Horner, T., Carver, J., Dumetrescu, T. P., He, Z., McCabe, M. T., Creasy, C. L., Dhar, A., Carpenter, C., & Johnson, P. M. (2016). A Phase I Study of GSK2816126, an Enhancer of Zeste Homolog 2(EZH2) Inhibitor, in Patients (pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Other Non-Hodgkin Lymphomas (NHL), Transformed Follicular Lymphoma (tFL), Solid Tumors and Multiple Myeloma (MM).

Chicago

Yap, Timothy Anthony, Jane N. Winter, John P. Leonard, Vincent Ribrag, Anastasia Constantinidou, Lisa Giulino-Roth, Jean-Marie Michot, et al. 2016. “A Phase I Study of GSK2816126, an Enhancer of Zeste Homolog 2(EZH2) Inhibitor, in Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Other Non-Hodgkin Lymphomas (NHL), Transformed Follicular Lymphoma (TFL), Solid Tumors and Multiple Myeloma (MM),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......4485..5181800bebed5cf8952e55b55696f0b9&authtype=sso&custid=ns315887.